KFDA lifts ban on Novartis flu vaccine

Published: 2012-11-14 07:00:00

Updated: 2012-11-14 07:00:00

The Korea Food and Drug Administration announced Monday it has lifted a ban on import of Agrippal junior prefilled syringe, an influenza vaccine made by Swiss pharmaceutical giant Novartis after documenting that concerns over impurities were unfounded.

"We lifts the suspension of import and us...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK